A Double-blind, Placebo-controlled Comparative Study and Open-label Extension Study to Confirm the Efficacy and Safety of E2020 in Subjects With Down Syndrome Having Regression Symptoms and Disabled Activities of Daily Living.
Clinical trial NCT02094053 · COMPLETED
Trial details
- NCT number
- NCT02094053
- Sponsor
- Eisai Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-12
- Primary completion
- 2016-09-16
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.